A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Four-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms HTX-011
- Sponsors Heron Therapeutics
- 23 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Sep 2015 Results published in Heron Therapeutics media release.
- 22 Sep 2015 Primary endpoint has been met. (SPI0-24), as per Heron Therapeutics media release.